RL 13 (Erlotinib 150 mg)
Pill with imprint RL 13 is White, Round and has been identified as Erlotinib 150 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RL 13
Erlotinib
- Imprint
- RL 13
- Strength
- 150 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Egfr inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 63304-0135
Related Images for "RL 13"
More about erlotinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: EGFR inhibitors
Consumer resources
- Other brands
- Tarceva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.